Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
2.915
+0.215 (7.96%)
Aug 14, 2025, 11:40 AM - Market open
Savara Market Cap
Savara has a market cap or net worth of $614.16 million as of August 14, 2025. Its market cap has increased by 1.01% in one year.
Market Cap
614.16M
Enterprise Value
451.72M
1-Year Change
1.01%
Ranking
Category
Stock Price
$2.92
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $614.16M, an increase of 362.82%. That is a compound annual growth rate of 20.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 466.70M | -11.43% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 587.32B |
| Johnson & Johnson | 418.23B |
| AbbVie | 354.53B |
| UnitedHealth Group | 242.86B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 225.04B |
| Novo Nordisk | 223.00B |